SKI Market

A+| A| A-|

Indian Indices

Sensex

77,496.36 609.45
( 0.79%)

Global Indices

Nasdaq

49,166.29 -22.51
(-0.05%)

Dow Jones

7,159.57 -35.34
(-0.49%)

Hang Seng

59,839.06 -698.30
(-1.15%)

Nikkei 225

10,332.91 11.82
(0.11%)

Forex

USD-INR

94.18 0.27
(0.28%)

EUR-INR

110.46 0.44
(0.40%)

GBP-INR

127.53 0.53
(0.42%)

JPY-INR

0.59 0.00
(0.34%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Shriram Finance Ltd

Industry : Finance & Investments

BSE Code

ISIN Demat

Book Value()

511218

INE721A01047

447.6708618

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SHRIRAMFIN

22.42

224140.44

EPS(TTM)

Face Value()

Div & Yield %

42.5

0.91

Back

Gland Pharma receives USFDA approval for Brimonidine Tartrate Ophthalmic Solution, 0.025%

Mar 04,2026

Gland Pharma has received tentative approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application filed for Brimonidine Tartrate Ophthalmic Solution, 0.025% (OTC).

The Product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Lumify Ophthalmic Solution, 0.025%, of Bausch & Lomb Inc.

This Product is indicated to relieve redness of the eye.

77,496.36 609.45 ( 0.79%)

49,166.29 -22.51 (-0.05%)

7,159.57 -35.34 (-0.49%)

59,839.06 -698.30 (-1.15%)

10,332.91 11.82 (0.11%)

94.18 0.27 (0.28%)

110.46 0.44 (0.40%)

127.53 0.53 (0.42%)

0.59 0.00 (0.34%)